Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells

Toxicology Letters

Volumn 184, Issue 3, 2009, Pages 204-210

  Yeh, Ming Hsien ^b   Kao, Shung Te ^c,d   Hung, Che Ming ^e   Liu, Ching Ju ^b   Lee, Kuo Hua ^e   Yeh, Chia Chou ^a,b  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e FISHERIES RESEARCH INSTITUTE   (Taiwan)

Author keywords

Acetaldehyde; Activator protein 1; Hesperidin; Matrix metalloproteinase 9; Nuclear factor B; Tumor invasion

Indexed keywords

ACETALDEHYDE; GELATINASE B; HESPERIDIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INVASION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME RELEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN TRANSPORT; TUMOR REGRESSION;

ACETALDEHYDE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; I-KAPPA B PROTEINS; INDOLES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; SULFONAMIDES; TRANSCRIPTION FACTOR AP-1;

EID: 58249142786     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2008.11.018     Document Type: Article

References (47)

1. Arii S., Mise M., Harada T., Furutani M., Ishigami S., Niwano M., Mizumoto M., Fukumoto M., and Imamura M. Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential. Hepatology 24 (1996) 316-322
2. Balakrishnan A., and Menon V.P. Effect of hesperidin on matrix metalloproteinases and antioxidant status during nicotine-induced toxicity. Toxicology 238 (2007) 90-98
3. Berkarda B., Koyuncu H., Soybir G., and Baykut F. Inhibitory effect of Hesperidin on tumour initiation and promotion in mouse skin. Res. Exp. Med. (Berl) 198 (1998) 93-99
4. Boffetta P., and Hashibe M. Alcohol and cancer. Lancet Oncol. 7 (2006) 149-156
5. Bosch F.X., Ribes J., Diaz M., and Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 127 (2004) S5-S16
6. Cheng J.C., Chou C.H., Kuo M.L., and Hsieh C.Y. Radiation enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-κB signal transduction pathway. Oncogene 25 (2006) 7009-7018
7. Chung T.W., Moon S.K., Lee Y.C., Kim J.G., Ko J.J., and Kim C.H. Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells. Arch. Biochem. Biophys. 408 (2002) 147-154
8. Corpet D.E., and Pierre F. Point: from animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiol. Biomarkers Prev. 12 (2003) 391-400
9. Donato F., Gelatti U., Limina R.M., and Fattovich G. Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence. Oncogene 25 (2006) 3756-3770
10. Gómez-Quiroz L.E., Paris R., Lluis J.M., Bucio L., Souza V., Hernández E., Gutiérrez M., Santiago M., García-Ruiz C., Fernández-Checa J.C., Kershenobich D., and Gutiérrez-Ruiz M.C. Differential modulation of interleukin 8 by interleukin 4 and interleukin 10 in HepG2 cells treated with acetaldehyde. Liver Int. 25 (2005) 122-130
11. Gutierrez-Ruiz M.C., Gomez Quiroz L.E., Hernandez E., Bucio L., Souza V., Llorente L., and Kershenobich D. Cytokine response and oxidative stress produced by ethanol, acetaldehyde and endotoxin treatment in HepG2 cells. Isr. Med. Assoc. J. 3 2 (2001) 131-136
12. Hayasaka A., Suzuki N., Fujimoto N., Iwama S., Fukuyama E., Kanda Y., and Saisho H. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma. Hepatology 24 (1996) 1058-1062
13. Hsiang C.Y., Wu S.L., Chen J.C., Lo H.Y., Li C.C., Chiang S.Y., Wu H.C., and Ho T.Y. Acetaldehyde induces matrix metalloproteinase-9 gene expression via nuclear factor-kappaB and activator protein 1 signaling pathways in human hepatocellular carcinoma cells: Association with the invasive potential. Toxicol. Lett. 171 (2007) 78-86
14. Hsiang C.Y., Wu S.L., and Ho T.Y. Morin inhibits 12-Otetradecanoylphorbol-13-acetate-induced hepatocellular transformation via activator protein 1 signaling pathway and cell cycle progression. Biochem. Pharmacol. 69 (2005) 1603-1611
15. Koyuncu H., Berkada B., Baykut F., Soybir G., Alatli C., Gui H., and Altun M. Preventive effect of hesperidin against inflammation in CD-1 mouse skin caused by tumor promoter. Anticancer Res. 19 (1999) 3237-3241
16. International Agency for Research on Cancer, 1999. Acetaldehyde. IARC Monogr. Eval. Carcinog. Risks Hum. 71, 319-335.
17. Justesen U., Knuthsen P., and Leth T. Quantitative analysis of flavonols, flavones, and flavanones in fruits, vegetables and beverages by high-performance liquid chromatography with photo-diode array and mass spectrometric detection. J. Chromatogr. A 799 (1998) 101-110
18. Kim E.S., Kim M.S., and Moon A. TGF-κ-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int. J. Oncol. 25 (2004) 1375-1382
19. Kim J.Y., Jung K.J., Choi J.S., and Chung H.Y. Modulation of the age-related nuclear factor-kappaB (NF-kappaB) pathway by hesperidin. Aging Cell 5 (2006) 401-411
20. Kubo S., Kinoshita H., Hirohashi K., Tanaka H., Tsukamoto T., Shuto T., and Kuroki T. High malignancy of hepatocellular carcinoma in alcoholic patients with hepatitis C virus. Surgery 121 (1997) 425-429
21. Lieber C.S. Mechanism of ethanol induced hepatic injury. Pharmacol. Ther. 46 (1990) 1-41
22. Lieber C.S. Hepatic and metabolic effects of ethanol: pathogenesis and prevention. Ann. Med. 26 (1994) 325-330
23. Liu J.F., Crepin M., Liu J.M., Barritault D., and Ledoux D. FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem. Biophys. Res. Commun. 293 (2002) 1174-1182
24. Maeda M., Nagawa H., Maeda T., Koike H., and Kasai H. Alcohol consumption enhances liver metastasis in colorectal carcinoma patients. Cancer 83 (1998) 1483-1488
25. Meloni F., Ballabio P., Gorrini M., De Amici M., Marena C., Malandrino S., and Luisetti M. Effects of 30-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products. Inflammation 19 (1995) 689-699
26. Morgan T.R., Mandayam S., and Jamal M.M. Alcohol and hepatocellular carcinoma. Gastroenterology 127 (2004) S87-S96
27. Nelson A.R., Fingleton B., Rothenberg M.L., and Matrisian L.M. Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol. 18 (2000) 1135-1149
28. Nielsen S.E., Freese R., Klemola P., and Mutanen M. Flavonoids in human urine as biomarkers for intake of fruits and vegetables. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 459-466
29. Pöoschl G., and Seitz H.K. Alcohol and cancer. Alcohol 39 (2004) 155-165
30. Pradeep K., Park S.H., and Ko K.C. Hesperidin a flavanoglycone protects against gamma-irradiation induced hepatocellular damage and oxidative stress in Sprague-Dawley rats. Eur. J. Pharmacol. 587 (2008) 273-280
31. Rintala J., Jaatinen P., Parkkila S., Sarviharju M., Kiianmaa K., Hervonen A., and Niemela O. Evidence of acetaldehyde-protein adduct formation in rat brain after lifelong consumption of ethanol. Alcohol Alcohol 35 (2002) 458-463
32. Rao J.S., Steck P.A., Mohanam S., Stetler-Stevenson W.G., Liotta L.A., and Sawaya R. Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. Cancer Res. 53 (1993) 2208-2211
33. Rao J.S., Yamamoto M., Mohaman S., Gokaslan Z.L., Fuller G.N., Stetler-Stevenson W.G., Rao V.H., Liotta L.A., Nicolson G.L., and Sawaya R.E. Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas. Clin. Exp. Metastasis 14 (1996) 12-18
34. Sakamoto Y., Mafune K., Mori M., Shiraishi T., Imamura H., Mori M., Takayama T., and Makuuchi M. Overexpression of MMP-9 correlates with growth of small hepatocellular carcinoma. Int. J. Oncol. 17 (2000) 237-243
35. Sato H., and Seiki M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8 (1993) 395-405
36. Scorilas A., Karameris A., Arnogiannaki N., Ardavanis A., Bassilopoulos P., Trangas T., and Talieri M. Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients. Br. J. Cancer 84 (2001) 1488-1496
37. Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin. Cancer Biol. 10 (2000) 415-433
38. Sugita K. Recent advances in inhibitors of metalloproteinases for cancer therapy. Drugs 2 (1999) 327-339
39. Tanaka T., Makita H., Ohnishi M., Mori H., Satoh K., Hara A., Sumida T., Fukutani K., and Ogawa H. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination. Cancer Res. 57 (1997) 246-252
40. Tanaka T., Makita H., Kawabata K., and Mori H. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis 18 (1997) 957-965
41. Tanaka T., Khono H., Murakami M., Shimada R., Kagami S., Sumida T., Azuma Y., and Ogawa H. Modulation of N-methyl-Namylnitrosamine-induced rat oesophageal tumourigenesis by dietary feeding of diosmin and hesperidin, both alone and in combination. Carcinogenesis 18 (1997) 761-769
42. Tanaka T., Khono H., Murakami M., Shimada R., Kagami S., Sumida T., Azuma Y., and Ogawa H. Suppression of azoxymethane-induced colon carcinogenesis in male F344 rats by mandarin juices rich in beta-cryptoxanthin and hesperidin. Int. J. Cancer 88 (2000) 146-150
43. Tirkey N., Pilkhwal S., Kuhad A., and Chopra K. Hesperidin, a citrus bioflavonoid, decreases the oxidative stress produced by carbon tetrachloride in rat liver and kidney. BMC Pharmacol. 5 (2005) 2
44. Vaca C.E., Nilsson J.A., Fang J.L., and Grafstrom R.C. Formation of DNA adducts in human buccal epithelial cells exposed to acetaldehyde and methylglyoxal in vitro. Chem. Biol. Interact. 108 (1998) 197-208
45. Wojtowicz-Praga S. Clinical potential of matrix metalloproteinase inhibitors. Drugs Res. Dev. 1 (1999) 117-129
46. Yang M., Tanaka T., Hirose Y., Deguchi T., Mori H., and Kawada Y. Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinarybladder carcinogenesis in male ICR mice. Int. J. Cancer 73 (1997) 719-724
47. Yeh C.C., Kao S.J., Lin C.C., Wang S.D., Liu C.J., and Kao S.T. The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitro. Life Sci. 80 (2007) 1821-1831